Inhibition of NLRP3 may attenuate myocarditis-induced dysregulations in Ca2+ and Na+ levels by downregulating the expression of ROS and CaMKII, thereby normalizing key electrical and structural parameters. The gene discussed is NLRP3; the disease is myocarditis.